What is Outcomes4me?
Outcomes4me operates at the intersection of artificial intelligence, machine learning, and oncology, offering a free digital platform designed to guide cancer patients through their treatment journey. By integrating with the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, the platform provides patients with physician-reviewed, regulatory-aligned treatment insights, information on clinical trials, and genetic testing options. This innovative approach aims to enhance transparency and support informed decision-making for patients navigating complex cancer care pathways.
How much funding has Outcomes4me raised?
Outcomes4me has raised a total of $37.8M across 4 funding rounds:
Other Financing Round
$4.7M
Debt
$149K
Series A
$12M
Other Financing Round
$21M
Other Financing Round (2020): $4.7M with participation from Merstal, Asset Management Ventures, and Sierra Ventures
Debt (2021): $149K led by PPP
Series A (2021): $12M supported by Sierra Ventures, asset management ventures, Merstal, Northpond Ventures, and IRA Capital
Other Financing Round (2025): $21M featuring Sierra Ventures, Northpond Ventures, and Silica Investments
Key Investors in Outcomes4me
Sierra Ventures
Sierra Ventures is a Silicon Valley-based venture capital firm that invests in early-stage technology startups, particularly in enterprise software, infrastructure, data/AI, and frontier tech. They partner with founders from product-market fit through scaleup and exit.
Northpond Ventures
Northpond Ventures is dedicated to advancing science and technology to create significant impacts on humanity, focusing on breakthrough innovations and entrepreneurial ventures. They aim to partner with innovators to drive meaningful change in the scientific landscape.
Asset Management Ventures
For over 45 years, Asset Management Company has partnered with visionary entrepreneurs to create valuable new companies and industries by investing capital in exciting, new, technology-based opportunities, taking a long-term view.
What's next for Outcomes4me?
The recent major strategic investment signals a pivotal phase for Outcomes4me, likely enabling the company to scale its operations, enhance its AI capabilities, and expand its reach within the oncology sector. This capital infusion is expected to accelerate product development and market penetration, further solidifying its role as a critical digital health resource for cancer patients and healthcare providers. The company's focus on evidence-based guidance and patient empowerment positions it for continued expansion and impact in the evolving landscape of cancer treatment.
See full Outcomes4me company page
